Eagle Pharmaceuticals Market Cap

Eagle Pharmaceuticals has a market cap or net worth of $41.67 million as of August 15, 2025. Its market cap has decreased by -12.56% in one year.

Market Cap

41.67M

Enterprise Value

n/a

Revenue

257.55M

Ranking

n/a

PE Ratio

3.51

Stock Price

$3.20

Market Cap Chart

Since February 12, 2014, Eagle Pharmaceuticals's market cap has increased from 39.11M to 41.67M, an increase of 6.56%. That is a compound annual growth rate of 0.55%.

Market Cap History

Date	Market Cap	% Change
Aug 11, 2025	41.67M	540.00%
Dec 31, 2024	6.51M	-90.41%
Dec 29, 2023	67.92M	-82.15%
Dec 30, 2022	380.45M	-42.14%
Dec 31, 2021	657.57M	8.37%
Dec 31, 2020	606.81M	-26.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	972.93M
Veradigm	781.22M
Tian'an Technology Group	628.15M
Glass House Brands	606.72M
Elite Pharmaceuticals	567.29M
American Oncology Network	389.51M
Northwest Biotherapeutics	351.78M
CytoDyn	336.73M

Market Cap Rankings